NO955059D0 - Peptider som utviser oksytocin antagonistisk aktivitet - Google Patents

Peptider som utviser oksytocin antagonistisk aktivitet

Info

Publication number
NO955059D0
NO955059D0 NO955059A NO955059A NO955059D0 NO 955059 D0 NO955059 D0 NO 955059D0 NO 955059 A NO955059 A NO 955059A NO 955059 A NO955059 A NO 955059A NO 955059 D0 NO955059 D0 NO 955059D0
Authority
NO
Norway
Prior art keywords
antagonistic activity
peptides showing
oxytocin antagonistic
oxytocin
peptides
Prior art date
Application number
NO955059A
Other languages
English (en)
Norwegian (no)
Other versions
NO955059L (no
Inventor
Carl-Johan Aurell
Per Melin
Anders Nilsson
Jerzy Trojnar
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO955059L publication Critical patent/NO955059L/no
Publication of NO955059D0 publication Critical patent/NO955059D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO955059A 1993-07-13 1995-12-13 Peptider som utviser oksytocin antagonistisk aktivitet NO955059D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9302414A SE501678C2 (sv) 1993-07-13 1993-07-13 Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
PCT/SE1994/000674 WO1995002609A1 (en) 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity

Publications (2)

Publication Number Publication Date
NO955059L NO955059L (no) 1995-12-13
NO955059D0 true NO955059D0 (no) 1995-12-13

Family

ID=20390606

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955059A NO955059D0 (no) 1993-07-13 1995-12-13 Peptider som utviser oksytocin antagonistisk aktivitet

Country Status (16)

Country Link
EP (1) EP0791012A1 (Direct)
JP (1) JPH09502427A (Direct)
KR (1) KR960702848A (Direct)
CN (1) CN1126999A (Direct)
AU (1) AU676071B2 (Direct)
CA (1) CA2163114A1 (Direct)
CZ (1) CZ9896A3 (Direct)
FI (1) FI960119L (Direct)
HU (1) HUT74874A (Direct)
IL (1) IL110267A0 (Direct)
NO (1) NO955059D0 (Direct)
PL (1) PL312568A1 (Direct)
SE (1) SE501678C2 (Direct)
TW (1) TW268009B (Direct)
WO (1) WO1995002609A1 (Direct)
ZA (1) ZA945090B (Direct)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604341D0 (sv) * 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
AU2003211011A1 (en) 2002-02-27 2003-09-09 Ferring Bv Intermediates and methods for making heptapeptide oxytocin analogues
CA3001057A1 (en) * 2015-10-06 2017-04-13 Ferring B.V. New methods for making barusiban and its intermediates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5373089A (en) * 1988-09-02 1994-12-13 Northwestern University Oxytocin antagonist
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel

Also Published As

Publication number Publication date
SE501678C2 (sv) 1995-04-10
CA2163114A1 (en) 1995-01-26
CZ9896A3 (en) 1996-06-12
NO955059L (no) 1995-12-13
AU676071B2 (en) 1997-02-27
WO1995002609A1 (en) 1995-01-26
TW268009B (Direct) 1996-01-11
SE9302414L (sv) 1995-01-14
EP0791012A1 (en) 1997-08-27
KR960702848A (ko) 1996-05-23
IL110267A0 (en) 1994-10-21
AU7240694A (en) 1995-02-13
PL312568A1 (en) 1996-04-29
FI960119A0 (fi) 1996-01-10
ZA945090B (en) 1995-02-22
FI960119A7 (fi) 1996-01-10
HUT74874A (en) 1997-02-28
SE9302414D0 (sv) 1993-07-13
HU9503768D0 (en) 1996-02-28
FI960119L (fi) 1996-01-10
JPH09502427A (ja) 1997-03-11
CN1126999A (zh) 1996-07-17

Similar Documents

Publication Publication Date Title
FI931967A0 (fi) Elektrostatisk separator som anvaender glaspaerlaskikt
FI935058L (fi) Foer antitumoerbehandling avsedda rekombinant-adenovirus som uttrycker cytokiner
FI931229A0 (fi) Som glanspigment laempade blandningar
FI934750A7 (fi) Kommunikationsfoerfarande i TDMA-cellulaermobilradiosystem som anvaender frekvenshoppning
FI930271A0 (fi) Katjonbytehartser som har foeroekad kapasitet foer jaernoxider
FI950729L (fi) Mitogeneesia ja motogeneesia inhiboivat peptidit
FI931278L (fi) Polymerer, som innehaoller sulfogrupper
FI931069L (fi) Kolloidalt rostat kaffe som aromatiseringsprodukt
FI953302L (fi) Uudet peptidit
FI933022A0 (fi) Radiosystem som bildar en traodloes lokalslinga
DE69413606D1 (de) Endothelinantagonistische Peptide
FI940109A7 (fi) Peptidejä
FI934751L (fi) Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner
FI934064A0 (fi) Anvaendning av tiadiazolfoereningar som aktivt aemne foer foerebyggande av bottenvaextlighet hos fartyg
NO955059D0 (no) Peptider som utviser oksytocin antagonistisk aktivitet
FI953646L (fi) Oksitosiiniantaginisti
FI932284L (fi) Kalciumkanaler blockerande polypeptider som haerstammar fraon filistata hibernalis
FI930217A7 (fi) Hoegt tvaerbundna, smaott avdunstande organiska foereningar innehaollande ytbelaeggningskompositioner som omfattar polyuretandispersioner
FI955896A7 (fi) Uudet aktiiviset yhdisteet
DE59401886D1 (de) Federnd nachgiebiger Fussboden
FI930385L (fi) Latexfaerg som taol loesningsmedel
FI960051L (fi) Difluoristatonianalogeja
FI924645L (fi) Snabbt upploesbart soetningsmedel som innehaoller karamell
FI810U1 (fi) Staell som underlaettar mattvaett
FI931598A0 (fi) Spelbraede foer som bokstavplattor formade spelbrickor